Cargando…
Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China
BACKGROUND: It is well demonstrated that immunosuppressants can reduce, but not eliminate the risk of generalized development in ocular myasthenia gravis (OMG). In this study, we aimed to explore the predictive factors of generalized conversion of OMG patients who received immunosuppressive treatmen...
Autores principales: | Ding, Jiaqi, Zhao, Sijia, Ren, Kaixi, Dang, Dan, Li, Hongzeng, Wu, Fang, Zhang, Min, Li, Zhuyi, Guo, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288410/ https://www.ncbi.nlm.nih.gov/pubmed/32527235 http://dx.doi.org/10.1186/s12883-020-01805-1 |
Ejemplares similares
-
Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset
por: Zhao, Sijia, et al.
Publicado: (2022) -
Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study
por: Zhao, Sijia, et al.
Publicado: (2021) -
Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients
por: Zhao, Sijia, et al.
Publicado: (2018) -
Do early prednisolone and other immunosuppressant therapies prevent
generalization in ocular myasthenia gravis in Western populations: a systematic
review and meta-analysis
por: Li, Mingxia, et al.
Publicado: (2019) -
Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis
por: Ruan, Zhe, et al.
Publicado: (2022)